Fairvalue-Calculator Fairvalue-Calculator

Jangho Group (601886) Fair Value & Analysis

Industrials · CN · Market cap 10.1B CNY

Price¥8.95
Fair Value¥11.31
Upside+26.4%
Quality89/100
Evidence: Medium Range ¥8.48 – ¥14.14

Analysis

Jangho Group (601886) currently trades at ¥8.95, while our model-based Fair Value estimate is ¥11.31 — implying the stock looks roughly 26.4% undervalued today. We read business quality at 89/100 (high quality), in the Industrials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.

About the company

Jangho Group Co., Ltd. engages in the building decoration and medical health businesses in China and internationally. It is involved in the interior decoration and design and building curtain wall, and photovoltaic building activities. The company also undertakes curtain wall projects for office buildings, hotels, commercial complexes, airports, railway stations, stadiums, etc. In addition, it offers interior decoration engineering services for public buildings, hotels, residences, rental apartments, and other projects; and produces and sells special-shaped photovoltaic modules. Further, the company operates a chain of ophthalmology hospitals for ophthalmic treatment and surgery, including cataract surgery, corneal transplant surgery, retinal surgery, intravitreal injection therapy, laser therapy, etc. Jangho Group Co., Ltd. was founded in 1999 and is headquartered in Beijing, China.

Open the full interactive analysis →

Similar stocks

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.